nirogacestat
springworks therapeutics
['defi ']
a phase iii trial of a notch inhibitor to treat desmoid tumors has reported impressive results at #esmo2022 . find out more about the defi trial here &gt;&gt;&gt; 
Oncology Central is the online resource for #oncology professionals, powered by Future Science Group. Senior Editors @JadeParkerB @racheljenkinsOC